A validation study of local steroid injection therapy with endoscopic tissue shielding method using polyglycolic sheet and fibrin glue for the prevention of stricture after entire circumferential esophageal endoscopic submucosal dissection (PF-E)
Not Applicable
- Conditions
- Early stage esophageal cancer after entire circumferential endoscopic submucosal dissection (ESD)
- Registration Number
- JPRN-UMIN000025447
- Lead Sponsor
- Shizuoka Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 11
Inclusion Criteria
Not provided
Exclusion Criteria
1) Active infection requiring systemic therapy 2) Pregnancy, possible pregnancy, within 28 days after delivery or breastfeeding 3) Hypersensitivity for triamcinolone acetone 4) Severe psychiatric disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of stenosis after ESD
- Secondary Outcome Measures
Name Time Method The number and period of endoscopic dilation, the coverage rate, the time of cover the mucosal defect, PGA sheets residual rate one week later, the number of endoscopic dilation of 12 weeks after ESD, stricture-free survival of 12 weeks after ESD, adverse events